Novo Holdings A/S - 13 Oct 2025 SCHEDULE 13G Report for 4D MOLECULAR THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (FDMT)

Filing Manager: Novo Holdings A/S
Reporting Manager: Novo Holdings A/S
Security: 4D MOLECULAR THERAPEUTICS, INC. Common Stock, par value $0.0001 per share
Symbol: FDMT
Shares outstanding: 46,691,176 shares
Disclosed Ownership: 3,175,000 shares
Ownership: 6.8%
Form type: SCHEDULE 13G
Filing time: 20 Oct 2025, 17:12:23 UTC
Date of event: 13 Oct 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Novo Holdings A/S	6.8%	3,175,000	3,175,000	0	Barbara Fiorini	Barbara Fiorini, General Counsel, Finance & Operations